炎症性肠病与前列腺癌风险关联的荟萃分析
该荟萃分析纳入9项研究,评估炎症性肠病(IBD)与前列腺癌(PCa)风险的关联。队列研究合并SIR为1.33(95%CI 1.03-1.71),溃疡性结肠炎(UC)患者PCa风险升高(SIR=1.58,95%CI 1.08-2.30),而克罗恩病(CD)患者未显著升高(SIR=1.12,95%CI 0.97-1.31);病例对照研究合并RR为1.81(95%CI 1.43-2.29)。
要点
- IBD患者前列腺癌风险总体升高,合并SIR为1.33。
- 溃疡性结肠炎患者风险显著升高,SIR为1.58。
- 克罗恩病患者风险未显著升高,SIR为1.12。
核心结论
- 基于大样本多中心数据,IBD尤其UC男性患者的前列腺癌风险显著升高。
研究设计与样本
- 系统检索PubMed、EMBASE和Web of Science数据库,最终纳入9项研究进行荟萃分析。
主要发现
- 队列研究合并SIR为1.33(95%CI 1.03-1.71)。
- UC患者PCa风险升高,合并SIR为1.58(95%CI 1.08-2.30)。
- CD患者PCa风险未显著升高,合并SIR为1.12(95%CI 0.97-1.31)。
- 三项病例对照研究合并RR为1.81(95%CI 1.43-2.29)。
- 敏感性分析结果稳健,未观察到显著发表偏倚。
临床怎么用
- 对IBD男性患者,尤其UC患者,应关注前列腺癌风险并考虑个体化筛查。
局限性
- 未来需明确IBD与PCa或临床显著PCa风险关联的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with inflammatory bowel disease (IBD) are at increased risk of gastrointestinal and extraintestinal malignancies. However, the associations between IBD and prostate cancer (PCa) risk remain conflicting. METHODS: We conducted a systematic literature search in PubMed, EMBASE, and Web of Science databases. According to the inclusion and exclusion criteria, a total of nine studies were included in the meta-analysis. The pooled standardized incidence ratios (SIRs) or relative risks (RRs) and corresponding 95% confidence intervals (CIs) were calculated to determine the relationship of IBD and PCa risk. RESULTS: For cohort studies, the pooled SIR was 1.33 (95% CI = 1.03-1.71). The further subgroup analysis showed that the PCa risk was higher in patients with ulcerative colitis (UC) (pooled SIR = 1.58, 95% CI = 1.08-2.30), but not in patients with Crohn's disease (CD) (pooled SIR = 1.12, 95% CI = 0.97-1.31). Besides, for the three case-control studies, the results indicated that compared with normal group, the pooled RR of PCa was 1.81 for the patients with IBD (95% CI = 1.43-2.29). In addition, sensitivity analysis indicated that the results were robust and no significant publication bias were observed. CONCLUSIONS: Our findings based on the large and multicenter samples strongly indicated that men with IBD especial UC have significantly elevated PCa risk. Future efforts are needed to define the mechanism underlying the link between IBD and PCa or clinically significant PCa risk.
引用
- Ge Y, Shi Q, Yao W, et al. The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis. 2019. PMID: 31591455. doi:10.1038/s41391-019-0177-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。